Childhood case of progressive multifocal leukoencephalopathy with improved clinical outcome

Ercan Demir1, Uwe G Liebert, Figen Söylemezoglu

  • 1Department of Pediatric Neurology, Hacettepe University, Ankara, Turkey.

Insights

This case study highlights long-term survival in a child with progressive multifocal leukoencephalopathy (PML) and normal immunity. It shows potential for recovery with treatment, even in rare neurological conditions.

Area of Science:

  • Neurology
  • Virology
  • Pediatric Oncology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, often fatal, demyelinating disease of the central nervous system.
  • PML is caused by the JC virus (JCV) and typically affects immunocompromised individuals.
  • This case involves a pediatric patient in remission from acute lymphoblastic leukemia (ALL).

Observation:

  • A 6-year-old boy, 2.5 years post-ALL remission, presented with neurological symptoms including seizures, hemiparesis, and visual loss.
  • Cranial MRI revealed white and gray matter lesions indicative of demyelination.
  • Diagnosis was confirmed by detecting JC virus DNA in brain tissue via PCR.

Findings:

  • The patient received a combination of anticonvulsants, amantadine, acyclovir, and ganciclovir.
  • Partial neurological recovery was observed following treatment.
  • This outcome is notable given the patient's normal immunologic parameters.

Implications:

  • This case suggests that long-term survival is possible in PML even with normal immune function.
  • It underscores the importance of considering PML in pediatric patients with neurological deficits, irrespective of perceived immune status.
  • Further research into treatment strategies for PML in immunocompetent individuals may be warranted.